GO:2000487 positive regulation of glutamine transport: Metabolic Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000487 (positive regulation of glutamine transport) describes any process that increases the frequency, rate or extent of glutamine transport across membranes.
• Glutamine is the most abundant circulating amino acid and a key fuel for rapidly proliferating cells, making its transport a critical control point in cancer and immune metabolism.
• Key transporters such as SLC1A5, SLC25A15, and SLC7A5 are frequently dysregulated in tumors and immune cells, directly impacting glutamine flux.
• Positive regulation of glutamine transport is intertwined with oncogenic signaling (e.g., MYC, mTORC1) and metabolic stress responses, offering therapeutic targets.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect the causal roles of transporters and regulators in glutamine transport.
• Understanding this process has implications for cancer, immune disorders, and metabolic diseases, with tools like SLC25A15 and GLS1 as emerging targets.
Description
Glutamine is the most abundant free amino acid in plasma and serves as a nitrogen donor and carbon source for biosynthetic pathways, particularly in rapidly dividing cells. The transport of glutamine across cellular membranes is therefore a tightly regulated process that determines its availability for metabolism. GO:2000487, positive regulation of glutamine transport, encompasses any molecular event that increases the frequency, rate, or extent of glutamine movement across membranes. This regulation is critical for normal physiology, including muscle glutamine turnover, and is hijacked in diseases such as cancer and immune dysfunction. Recent studies have identified key transporters and regulators, such as SLC1A5 and SLC25A15, whose expression or activity is modulated by oncogenic signals and metabolic stress. Understanding how glutamine transport is positively regulated provides insight into metabolic reprogramming and offers potential therapeutic targets. This article synthesizes current knowledge from authoritative QuickGO annotations and PubMed literature to outline the mechanisms, genes, and research methods relevant to GO:2000487.
positive regulation of glutamine transport At A Glance
| GO ID | GO:2000487 |
|---|---|
| GO term | positive regulation of glutamine transport |
| Ontology | biological_process |
| Synonym | positive regulation of L-glutamine transport |
| Major function | Upregulation of glutamine transport activity or expression |
| Related transporters | SLC1A5, SLC25A15, SLC7A5, SLC38A1, SLC38A2 |
| Key regulators | MYC, mTORC1, ATF4, GLS1 |
| Disease relevance | Cancer, immune disorders, metabolic diseases |
What Is GO:2000487?
According to the Gene Ontology, GO:2000487 (positive regulation of glutamine transport) is defined as any process that activates or increases the frequency, rate or extent of glutamine transport. This biological process does not directly perform transport but instead modulates the activity or expression of glutamine transporters, thereby enhancing the movement of glutamine across cellular membranes. It is synonymous with positive regulation of L-glutamine transport and is distinct from the transport process itself (GO:0006868).
Why Is positive regulation of glutamine transport Important in Cell Biology?
Positive regulation of glutamine transport is a central node in metabolic reprogramming, enabling cells to meet increased demands for glutamine during proliferation, immune activation, and stress responses. In cancer, upregulated glutamine transport supports biosynthetic and bioenergetic needs, and its inhibition can suppress tumor growth. In immune cells, glutamine transport influences T cell activation and antitumor immunity. Thus, understanding this process is vital for developing therapies targeting metabolic vulnerabilities.
• Supports rapid cell proliferation by supplying glutamine for nucleotide and protein synthesis.
• Enables immune cell activation and effector functions, including CD8+ T cell antitumor immunity.
• Contributes to cancer metabolic reprogramming and tumor progression.
• Modulates redox homeostasis and ferroptosis sensitivity in diseases like endometriosis.
• Influences skeletal muscle glutamine turnover and nitrogen balance.
• Links to oncogenic signaling pathways such as MYC and mTORC1.
• Potential therapeutic target for hepatocellular carcinoma and other cancers.
• Plays a role in arterial calcification via glutamate metabolism.
• Provides biomarkers for metabolic disorders and cancer diagnostics.
• Offers opportunities for CRISPR-based functional genomics screens.
What Happens During positive regulation of glutamine transport?
Transcriptional Upregulation of Glutamine Transporters
In simple terms: Cells make more transporter proteins by turning on their genes.
Positive regulation often begins with increased transcription of genes encoding glutamine transporters, such as SLC1A5 and SLC7A5. Oncogenic transcription factors like MYC directly promote the expression of these transporters to enhance glutamine uptake. In hepatocellular carcinoma, hypoxia-inducible factors can upregulate SLC25A15, a mitochondrial glutamine transporter, thereby increasing glutamine flux into mitochondria.
Post-translational Modification and Trafficking
In simple terms: Existing transporters are modified or moved to the cell surface to work harder.
Transporters can be activated by post-translational modifications or redirected to the plasma membrane. For instance, the serotonylation of GAPDH couples glycolytic metabolism to antitumor immunity, indirectly influencing glutamine transport dynamics. Additionally, signaling via mTORC1 promotes the surface localization of nutrient transporters, including those for glutamine, to support cell growth.
Metabolic Feedback and Signaling
In simple terms: The cell senses glutamine levels and adjusts transport accordingly.
Intracellular glutamine levels feed back on transport activity. For example, GLS1-mediated glutamate production can signal through NMDAR/Ca2+/β-catenin pathways to modulate glutamine transport in arterial calcification. In immune cells, glutamine metabolic competition drives immunosuppressive reprogramming, highlighting the interplay between transport and signaling.
Interaction with Other Metabolic Pathways
In simple terms: Glutamine transport is coordinated with other metabolic processes.
Positive regulation of glutamine transport is integrated with glycolysis and oxidative phosphorylation. Reductive glutamine metabolism by IDH1 under hypoxia requires increased glutamine uptake to support lipogenesis. Similarly, SLC1A5 regulation of glutamine metabolism promotes ferroptosis sensitivity in endometriosis, linking transport to iron-dependent cell death.
Key Genes Involved in GO:2000487 positive regulation of glutamine transport
The following genes and proteins are central to the positive regulation of glutamine transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC1A5 | Plasma membrane glutamine transporter | Promotes ferroptosis sensitivity in endometriosis |
| SLC25A15 | Mitochondrial glutamine transporter | Hypoxia-responsive, promotes hepatocellular carcinoma |
| SLC7A5 | L-type amino acid transporter | Supports tumor growth and immune cell function |
| SLC38A1 | System A glutamine transporter | Regulates glutamine uptake in cancer |
| SLC38A2 | System A glutamine transporter | Involved in metabolic stress responses |
| GLS1 | Glutaminase, converts glutamine to glutamate | Links to arterial calcification |
| IDH1 | Isocitrate dehydrogenase, reductive glutamine metabolism | Mediates lipogenesis under hypoxia |
| MYC | Oncogenic transcription factor | Upregulates glutamine transporters |
| mTORC1 | Kinase complex, regulates cell growth | Promotes transporter surface expression |
| ATF4 | Stress-responsive transcription factor | Induces glutamine transporters under stress |
| GAPDH | Glycolytic enzyme, serotonylation target | Couples glycolysis to antitumor immunity |
| GPR109A | G-protein coupled receptor | Drives immunosuppressive reprogramming |
| NMDAR | Glutamate receptor | Activates β-catenin pathway in calcification |
| β-catenin | Transcription co-activator | Mediates NMDAR signaling |
| SLC3A2 | Chaperone for SLC7A5 | Facilitates glutamine transport |
| SLC43A1 | L-type amino acid transporter | Contributes to glutamine uptake |
| SLC43A2 | L-type amino acid transporter | Regulates glutamine transport in immune cells |
How Is positive regulation of glutamine transport Regulated?
Positive regulation of glutamine transport is controlled at multiple levels. Transcriptionally, oncogenes such as MYC and stress-responsive factors like ATF4 increase the expression of transporters including SLC1A5 and SLC7A5. Post-translationally, mTORC1 signaling promotes the trafficking of these transporters to the plasma membrane. Metabolic feedback loops, such as those involving GLS1 and NMDAR signaling, further modulate transport activity. Additionally, the tumor microenvironment can influence glutamine transport through competition and immunosuppressive signals.
positive regulation of glutamine transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC25A15 | Hepatocellular carcinoma | Knockout in HepG2 cells |
| SLC1A5 | Endometriosis | Overexpression in endometrial stromal cells |
| GLS1 | Arterial calcification | Point mutation in vascular smooth muscle cells |
| GPR109A | Liver cancer progression | Knockout in myeloid cells |
| GAPDH | Antitumor immunity | Knock-in of serotonylation site in T cells |
Cancer Metabolism and Tumor Progression
Upregulated glutamine transport is a hallmark of many cancers, supporting biosynthetic demands. In hepatocellular carcinoma, SLC25A15 deficiency promotes tumor growth by reprogramming glutamine metabolism, highlighting the importance of mitochondrial glutamine transport. Similarly, glutamine metabolic competition in the tumor microenvironment drives immunosuppressive reprogramming of myeloid cells, facilitating liver cancer progression.
Immune Regulation and Immunotherapy
Glutamine transport is critical for T cell activation and antitumor immunity. A GAPDH serotonylation system couples CD8+ T cell glycolytic metabolism to antitumor immunity, indirectly affecting glutamine transport. Targeting glutamine transport may enhance immunotherapeutic strategies.
Metabolic and Musculoskeletal Disorders
In skeletal muscle, glutamine transport regulates turnover and nitrogen balance, with implications for catabolic conditions. In endometriosis, SLC1A5-mediated glutamine metabolism promotes ferroptosis sensitivity, suggesting a role in disease pathology.
Vascular Calcification
GLS1-mediated glutamate production activates NMDAR/Ca2+/β-catenin signaling, accelerating arterial calcification, which may involve altered glutamine transport.
From positive regulation of glutamine transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC25A15 loss affect glutamine transport? | SLC25A15 knockout in hepatocellular carcinoma cells |
| Does SLC1A5 overexpression increase ferroptosis? | SLC1A5 overexpression in endometriosis cells |
| Does GLS1 mutation alter arterial calcification? | GLS1 point mutation knock-in in vascular smooth muscle cells |
| Does GPR109A knockout affect immunosuppression? | GPR109A knockout in myeloid cells |
| Does GAPDH serotonylation regulate T cell immunity? | GAPDH knock-in of serotonylation site in CD8+ T cells |
| Does IDH1 reductive metabolism require glutamine transport? | IDH1 knockout under hypoxia |
How to Study the positive regulation of glutamine transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C-glutamine tracing | Glutamine uptake and metabolic fate | Cancer metabolism studies |
| CRISPR knockout screen | Genes affecting glutamine transport | Identify novel regulators |
| RNA-seq | Transporter gene expression | Transcriptional regulation |
| Proteomics | Protein levels and modifications | Post-translational regulation |
| Glutamine uptake assay | Transport activity | Functional validation |
| Immunofluorescence | Transporter localization | Trafficking studies |
| Western blot | Protein expression | Validation of knockout/overexpression |
| Metabolomics | Intracellular metabolite levels | Metabolic reprogramming |
Metabolic Flux Analysis
Isotope tracing with 13C-glutamine can measure glutamine uptake and its contribution to biosynthetic pathways. This method has been used to demonstrate reductive glutamine metabolism by IDH1 under hypoxia.
CRISPR Screens
Genome-wide CRISPR knockout screens can identify regulators of glutamine transport. For example, screens in cancer cells have uncovered SLC25A15 as a hypoxia-responsive gene promoting hepatocellular carcinoma.
Transcriptomics and Proteomics
RNA-seq and proteomics can quantify expression changes in glutamine transporters and regulators. Studies on SLC1A5 in endometriosis used such approaches to link transport to ferroptosis.
Functional Assays
Glutamine uptake assays using radiolabeled or fluorescent glutamine analogs directly measure transport activity. These assays are essential to validate findings from genetic screens.
How CRISPR Can Be Used to Study GO:2000487 positive regulation of glutamine transport
Knockout
CRISPR knockout of glutamine transporters such as SLC1A5 or SLC25A15 can abolish specific transport activities, revealing their contribution to cellular metabolism and disease. For instance, SLC25A15 knockout in hepatocellular carcinoma cells demonstrated its role in promoting tumor growth.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to disrupt post-translational modification sites. For example, mutating the serotonylation site on GAPDH can test its role in T cell immunity.
Knock-in
Knock-in of tagged transporters (e.g., GFP-SLC1A5) allows live-cell imaging and localization studies. This approach can reveal how transporters are trafficked to the membrane under positive regulation.
Overexpression
Overexpression of glutamine transporters like SLC1A5 can increase glutamine uptake and drive phenotypes such as ferroptosis sensitivity in endometriosis. This is useful to study gain-of-function effects.
How EDITGENE Supports positive regulation of glutamine transport Research
Researchers studying positive regulation of glutamine transport-related genes often need to determine whether a candidate gene is causally involved in transport regulation or is merely correlated with metabolic changes. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of glutamine transport research.
Frequently Asked Questions About positive regulation of glutamine transport
What is GO:2000487?
GO:2000487 is the Gene Ontology term for positive regulation of glutamine transport, defined as any process that activates or increases the frequency, rate or extent of glutamine transport.
What genes are involved in positive regulation of glutamine transport?
Key genes include SLC1A5, SLC25A15, SLC7A5, GLS1, MYC, and mTORC1, among others.
How is glutamine transport regulated in cancer?
In cancer, oncogenes like MYC upregulate transporter expression, and mTORC1 promotes their surface localization, enhancing glutamine uptake to support growth.
What diseases are associated with glutamine transport dysregulation?
Diseases include hepatocellular carcinoma, endometriosis, arterial calcification, and immune disorders.
What methods are used to study positive regulation of glutamine transport?
Methods include CRISPR screens, isotope tracing, RNA-seq, proteomics, and glutamine uptake assays.
How can CRISPR help study glutamine transport?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of transporters and regulators.
What is the role of SLC1A5 in glutamine transport?
SLC1A5 is a plasma membrane glutamine transporter that promotes ferroptosis sensitivity in endometriosis.
What is the role of SLC25A15 in cancer?
SLC25A15 is a mitochondrial glutamine transporter; its deficiency promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
How does glutamine transport affect immune cells?
Glutamine transport supports T cell activation and antitumor immunity, and its competition in the tumor microenvironment can drive immunosuppression.
What is the connection between glutamine transport and arterial calcification?
GLS1-mediated glutamate production activates NMDAR/Ca2+/β-catenin signaling, accelerating arterial calcification, which may involve altered glutamine transport.
Conclusion
Positive regulation of glutamine transport (GO:2000487) is a critical biological process that controls glutamine availability for metabolism, influencing cancer, immunity, and other diseases. Key transporters and regulators have been identified, and CRISPR-based models are powerful tools to dissect their functions. EDITGENE provides comprehensive services to support such research, from knockout to overexpression and screening.
References
- 1. Wang X et al.. 2024. A GAPDH serotonylation system couples CD8(+) T cell glycolytic metabolism to antitumor immunity.. Mol Cell 84(4):760-775.e7 PMID: 38215751
- 2. Metallo CM et al.. 2011. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia.. Nature 481(7381):380-4 PMID: 22101433
- 3. Hundal HS. 1991. Role of membrane transport in the regulation of skeletal muscle glutamine turnover.. Clin Nutr 10 Suppl:33-42 PMID: 16839953
- 4. Zhang Q et al.. 2024. Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism.. J Hepatol 80(2):293-308 PMID: 38450598
- 5. Yang Y et al.. 2025. Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A(+) myeloid cells to promote liver cancer progression.. Gut 74(2):255-269 PMID: 38981667
- 6. Zhou Z et al.. 2025. GLS1-Mediated Redundancy in Glutamate Accelerates Arterial Calcification via Activating NMDAR/Ca(2+)/β-Catenin Pathway.. Adv Sci (Weinh) 12(21):e2414252 PMID: 40289670
- 7. Ma HY et al.. 2025. Mechanism of SLC1A5 Regulation of Glutamine Metabolism to Promote Ferroptosis Sensitivity in Endometriosis.. Front Biosci (Landmark Ed) 30(5):36781 PMID: 40464516
